Armodafinil
C10953/3069/ES/MN
Phase 3 small_molecule terminated
Quick answer
Armodafinil for Traumatic Brain Injury is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Traumatic Brain Injury
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated